Literature DB >> 805176

Immunosuppression induced in vitro by mastocytoma tumor cells and cell-free extracts.

I Kamo, C Patel, J Kateley, H Friedman.   

Abstract

Suppressed anti-sheep RBC responses occurred when spleen cells from mastocytoma-bearing mice were incubated in vitro and immunized with red blood cells. Marked immunosuppression also occurred when mastocytoma cells were added to spleen cell cultures from normal mice immunized in vitro with the sheep RBC. Suppressed immune responses also occurred when the mastocytoma cells were separated from the normal cells by 0.4-mu nucleopore membranes, but not by dialysis membranes in double chambered culture vessels. Cell-free homogenates prepared from mastocytoma cells, as well as ascitic fluid from tumor-bearing mice, also impaired the responsiveness of normal splenocytes to the SRBC. The suppressive activity of the cell-free homogenates was abolished by heating at 56 degrees C for 30 min. The immunosuppressive activity, however, was retained in supernatant ultracentrifugates of the cell-free homogenate after 100,000 times G for 90 min. Immunosuppression was most evident when mastocytoma extracts were added to cultures of normal splenocytes at the time of in vitro immunization and culture initiation. Suppression was not reversed by washing of the cultured cells and addition of fresh medium. Immunosuppression also occurred when mastocytoma extracts were incubated with spleen cells from allogeneic tumor resistant C57BL/6 mice. Additional physicochemical analyses should provide information as to the nature and specificty of the inhibitory factor(s) and its role as an immunoregulatory substance important in the host-tumor relationship.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 805176

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  11 in total

1.  Immunosuppression in plasmacytoma: induction of suppressor cells.

Authors:  Y Chen; L T Hwang; P Heller
Journal:  Clin Exp Immunol       Date:  1982-01       Impact factor: 4.330

2.  Tumour-associated inhibition of immediate hypersensitivity reactions in mice.

Authors:  N R Lynch; J C Salomon
Journal:  Immunology       Date:  1977-05       Impact factor: 7.397

3.  Tumor-induced immunosuppression.

Authors:  H Friedman; S Specter; M Watanabe; S H Pan
Journal:  Am J Pathol       Date:  1978-11       Impact factor: 4.307

4.  The mode of action of splenic suppressor cells in murine plasmacytoma.

Authors:  Y Chen; P Heller
Journal:  Clin Exp Immunol       Date:  1981-09       Impact factor: 4.330

5.  Diffusible suppressor factor from splenic macrophages in murine plasmacytoma.

Authors:  Y H Chen; P Heller
Journal:  Clin Exp Immunol       Date:  1984-07       Impact factor: 4.330

6.  The primary immune response of patients with different stages of squamous-cell bronchial carcinoma.

Authors:  H M Jansen; T H The; G C de Gast; M T Esselink; G Pastoor; N G Orie
Journal:  Thorax       Date:  1978-12       Impact factor: 9.139

7.  Suppressor activity of splenic macrophages in murine plasmacytoma (PC) is inhibited by PC specific ligands.

Authors:  Y H Chen; P Heller
Journal:  Clin Exp Immunol       Date:  1982-11       Impact factor: 4.330

8.  Immunomodulating effects in vitro of a hydroxythiazolobenzimidazole in the absence of mitogenicity.

Authors:  G H Warren; L Mills; H Friedman
Journal:  Experientia       Date:  1978-06-15

9.  Immunosuppressive activity of a subline of the mouse EL-4 lymphoma. Evidence for minute virus of mice causing the inhibition.

Authors:  G D Bonnard; E K Manders; D A Campbell; R B Herberman; M J Collins
Journal:  J Exp Med       Date:  1976-01-01       Impact factor: 14.307

10.  Inhibition of lymphocyte trapping by a passenger virus in murine ascitic tumors: characterization of lactic dehydrogenase virus (LDV) as the inhibitory component and analysis of the mechanism of inhibition.

Authors:  P K Mongini; L T Rosenberg
Journal:  J Exp Med       Date:  1976-01-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.